Petros Pharmaceuticals Accounts Payable

Petros Pharmaceuticals (PTPI) currently reports a accounts payable of $130K as of March 2026. That compares with $760K in the prior-year period — down 82.4% year over year. Use the charts on this page to explore Petros Pharmaceuticals's accounts payable history and peer comparisons.

Petros Pharmaceuticals's accounts payable decreased from $760K to $130K — a 82.4% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Petros Pharmaceuticals reported $130K in accounts payable as of March 2026. That compares with $760K in the prior-year period — down 82.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $130K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Petros Pharmaceuticals, and consider following PTPI for alerts when major investors trade the stock.

Petros Pharmaceuticals is classified in the Healthcare sector. On accounts payable, it currently shows $130K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing PTPI with unrelated industries.